Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • yaximik
    Senior Member
    • Apr 2011
    • 199

    New reagent kits

    I just received 2013 price list. Aside about $200 hike for standard MiSeq reagent kits, I noticed new micro an nano kits, which are cheaper than standard kits for the same number of cycles. My understanding from previous discussions that micro and nano cells are the same standard cells with etched-out tiles. That is the volumes should be the same - what makes kits cheaper then? Has anyone seen these kits yet?
  • mcnelson.phd
    Senior Member
    • Jul 2011
    • 162

    #2
    Here's the information that I know from Illumina so far:

    The standard kits image 14 total tiles on both surfaces of the flow-cell. Micro kits will image 4 tiles on both surfaces while the Nano will image only 2 tiles on one surface. The different flow-cells will come in color coded vials so you know which is which.

    As for the price differences, the reagents themselves are pretty cheap compared to the flow-cell itself, so my presumption is that the Micro and Nano flow-cells are cheaper to produce and that more pass quality control, thus lowering the cost of the kit overall. Illumina also is making pretty nice margins off these kits, so there's probably a lot of price discrimination going on.

    The question is why would anyone use a Micro or Nano kit over a standard kit given that the price difference isn't that great compared to the yield you get. Since these kits are supposedly going to be marketed as a way to validate your library, I can see the justification that choosing a Nano kit over a standard 50 cycle will give you a better idea if things are going to work as expected.

    Finally, I can't wait to hear what the mad-hatters at the Broad do with these kits.

    Comment

    • GenoMax
      Senior Member
      • Feb 2008
      • 7142

      #3
      Micro and nano kits allow for extremely fast runs. For some applications it may be justifiable to pay the price for this convenience.

      Comment

      • TonyBrooks
        Senior Member
        • Jun 2009
        • 303

        #4
        We potentially have a few projects that just don't need 15 million reads. It's actually beneficial for us to do two Nano runs and process twice the number of samples than one V2 run with more reads per sample. At the moment, we're limited by the number of indexes we have.

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by mylaser
          Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
          If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
          This guide explains everything you need to know about...
          Today, 01:13 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-02-2026, 11:08 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Working...